Date | Insider | Price | Amount |
---|---|---|---|
10-19-2023 Insider Buy |
Dror Bashan PRESIDENT AND CEO |
$1.40 CAGR » |
$90,483.69 64,516 shares |
4-11-2022 Insider Buy |
Dror Bashan President and CEO |
$1.50 CAGR » |
$102,000.00 68,000 shares |
4-7-2020 Insider Buy |
Aharon Schwartz Director |
$2.43 CAGR » |
$155,264.00 64,000 shares |
5-16-2017 Insider Buy |
Moshe Manor President & CEO |
$0.81 CAGR » |
$40,500.00 50,000 shares |
12-14-2015 Insider Buy |
Yossi Maimon Vice President & CFO |
$0.78 CAGR » |
$7,800.00 10,000 shares |
10-19-2015 Insider Buy |
Camber Capital Management LLC >10% Owner |
$1.00 CAGR » |
$4,000,435.69 4,000,423 shares |
12-2-2009 Insider Buy |
Amos Bar-shalev Director |
$8.49 CAGR » |
$14,256.00 1,680 shares |
Also See: Institutional Holders of PLX
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 10/20/2023 | |
End date: | 05/07/2024 | |
Start price/share: | $1.50 | |
End price/share: | $1.14 | |
Dividends collected/share: | $0.00 | |
Total return: | -24.00% | |
Annualized Gain: | -43.80% | |
Starting investment: | $10,000.00 | |
Ending investment: | $7,600.00 | |
Years: | 0.55 |
Protalix BioTherapeutics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Protalix BioTherapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding PLX
Free PLX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Protalix BioTherapeutics Insider Buying occurred are:
MiNK Therapeutics Insider Buying |